Macromolecular Antiviral Agents Against Zika, Ebola, SARS, and Other Pathogenic Viruses

Advanced healthcare materials - United Kingdom
doi 10.1002/adhm.201700748
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Antiviral Agents in Development for Zika Virus Infections

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2019English

Integrated Human-Virus Metabolic Stoichiometric Modelling Predicts Host-Based Antiviral Targets Against Chikungunya, Dengue and Zika Viruses

Journal of the Royal Society Interface
BiochemistryBiophysicsBiomaterialsBiotechnologyBioengineeringBiomedical Engineering
2018English

Antiviral Effects of Green Tea (Camellia Sinensis) Against Pathogenic Viruses in Human and Animals (A Mini-Review)

African Journal of Traditional, Complementary and Alternative Medicines
MedicineDrug DiscoveryAlternative MedicineComplementary
2016English

Virus Against Virus: A Potential Treatment for 2019-nCov (SARS-CoV-2) and Other RNA Viruses

Cell Research
Cell BiologyMolecular Biology
2020English

Antiviral Activity of Resveratrol Against Human and Animal Viruses

Advances in Virology
VirologyInfectious Diseases
2015English

Antihistaminics, Local Anesthetics, and Other Amines as Antiviral Agents.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Potent Human Monoclonal Antibodies Against SARS CoV, Nipah and Hendra Viruses

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2009English

Sofosbuvir: An Antiviral Drug With Potential Efficacy Against Zika Infection

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Antiviral Agents and Corticosteroids in the Treatment of Severe Acute Respiratory Syndrome (SARS)

Thorax
PulmonaryRespiratory Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy